140 related articles for article (PubMed ID: 27986202)
21. [From comparative effectiveness research to patient-centered outcomes research].
Gerhardus A; Schmacke N
Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):477-8. PubMed ID: 22981022
[No Abstract] [Full Text] [Related]
22. Perspectives on health technology assessment in Latin America. The case of perinatal care in the literature.
Panerai RB; Almeida RT; Freire SM; Chaim DM; Miranda MZ; Madureira LC; Aguiar Neto MA
Int J Technol Assess Health Care; 1993; 9(1):76-84. PubMed ID: 8423118
[TBL] [Abstract][Full Text] [Related]
23. US healthcare reform: implications for health economics and outcomes research.
Chambers JD; Neumann PJ
Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):215-6. PubMed ID: 20545583
[No Abstract] [Full Text] [Related]
24. A national data infrastructure for patient-centered outcomes research.
Dymek C; Gingold J; Shanbhag A; Fridsma D; Yong PL
J Comp Eff Res; 2015 Jan; 4(1):75-87. PubMed ID: 25565070
[TBL] [Abstract][Full Text] [Related]
25. From comparative effectiveness research to patient-centered outcomes research: policy history and future directions.
D'Arcy LP; Rich EC
Neurosurg Focus; 2012 Jul; 33(1):E7. PubMed ID: 22746239
[TBL] [Abstract][Full Text] [Related]
26. The researcher-in-chief at the Patient-Centered Outcomes Research Institute. Interview by Susan Dentzer.
Selby JV
Health Aff (Millwood); 2011 Dec; 30(12):2252-8. PubMed ID: 22147852
[No Abstract] [Full Text] [Related]
27. Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences.
Augustovski F; Alcaraz A; Caporale J; García Martí S; Pichon Riviere A
Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):9-12. PubMed ID: 25420744
[TBL] [Abstract][Full Text] [Related]
28. PCORI, comparative effectiveness and the ACA: improving patient outcomes or cookbook medicine?
Fontenot SF
Physician Exec; 2013; 39(4):98-102. PubMed ID: 23923719
[No Abstract] [Full Text] [Related]
29. The Patient-centered Outcomes Research Institute's Role in Advancing Methods for Patient-centered Outcomes Research.
Fleurence R; Whicher D; Dunham K; Gerson J; Newhouse R; Luce B
Med Care; 2015 Jan; 53(1):2-8. PubMed ID: 25334055
[No Abstract] [Full Text] [Related]
30. Health economics and outcomes research within drug development: challenges and opportunities for reimbursement and market access within biopharma research.
van Nooten F; Holmstrom S; Green J; Wiklund I; Odeyemi IA; Wilcox TK
Drug Discov Today; 2012 Jun; 17(11-12):615-22. PubMed ID: 22366662
[TBL] [Abstract][Full Text] [Related]
31. Pharmacoeconomics and outcomes research.
Bootman JL
Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S16-9. PubMed ID: 7552912
[No Abstract] [Full Text] [Related]
32. 1st Annual International Meeting of the Association for Pharmacoeconomics and Outcomes Research. Philadelphia, Pennsylvania, May 12-15, 1996. Abstract.
Clin Ther; 1996; 18 Suppl A():1-66. PubMed ID: 8976391
[No Abstract] [Full Text] [Related]
33. How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.
Selby J; Slutsky J
J Comp Eff Res; 2014 Nov; 3(6):565-6. PubMed ID: 25494560
[No Abstract] [Full Text] [Related]
34. The patient-centered outcomes research institute should focus on high-impact problems that can be solved quickly.
Sox H
Health Aff (Millwood); 2012 Oct; 31(10):2176-82. PubMed ID: 23048093
[TBL] [Abstract][Full Text] [Related]
35. Interview: Health technology assessment in Asia: an emerging trend.
Yang BM
J Comp Eff Res; 2012 May; 1(3):221-4. PubMed ID: 24237405
[TBL] [Abstract][Full Text] [Related]
36. Patient-centered research and vulnerable populations.
Douglas MD
Health Aff (Millwood); 2013 Feb; 32(2):439. PubMed ID: 23381543
[No Abstract] [Full Text] [Related]
37. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 7th Annual International Meeting. May 19-22, 2002. Arlington, Virginia, USA. Abstracts.
Value Health; 2002; 5(3):117-294. PubMed ID: 12010559
[No Abstract] [Full Text] [Related]
38. International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework.
Malone DC; Berg NS; Claxton K; Garrison LP; IJzerman M; Marsh K; Neumann PJ; Sculpher M; Towse A; Uyl-de Groot C; Weinstein MC
J Clin Oncol; 2016 Aug; 34(24):2936-7. PubMed ID: 27298420
[No Abstract] [Full Text] [Related]
39. Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region.
Yang BM; Lee K
Value Health; 2009; 12 Suppl 3():S1-2. PubMed ID: 20586968
[No Abstract] [Full Text] [Related]
40. Comparative effectiveness research: a view from the other side of the pond.
Rawlins MD
J Comp Eff Res; 2012 May; 1(3):293-5. PubMed ID: 24237410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
